Literature DB >> 2018022

Black-white differences in stage-specific cancer survival: analysis of seven selected sites.

K E Ragland1, S Selvin, D W Merrill.   

Abstract

A number of researchers have noted that the black population in the United States generally has less favorable cancer survival than does the white population. It is not clear, however, whether this difference is fully explained by differences in stage of disease at diagnosis. This study uses Surveillance, Epidemiology, and End Results program data from the San Francisco-Oakland (California) Metropolitan Statistical Area for the years 1974-1985 to study survival differences between blacks and whites while controlling for both stage and age at diagnosis. The cancer sites examined are those for which mortality is considered avoidable by early detection and treatment, namely the colon, rectum, bladder, breast, cervix, uterine corpus, and prostate. Stage-specific (local, regional, and remote) survival curves are examined for each cancer site. The site- and stage-specific curves for colon, male rectal, and prostate cancer, supplemented by proportional hazards analyses, indicate no significant stage-specific racial differentials. Stage-specific survival differentials persist for male bladder, female rectal, and breast cancer. The relation between race and stage is more complex for female bladder, cervical, and uterine corpus cancer; for these sites, there is a racial difference at some stages but not all. The consequences for secondary intervention programs are considered for the seven sites in light of these findings.

Entities:  

Mesh:

Year:  1991        PMID: 2018022     DOI: 10.1093/oxfordjournals.aje.a115942

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

1.  Cancer in the African American. The annual William E. Allen, Jr, MD, Memorial Lecture.

Authors:  C M Mansfield
Journal:  J Natl Med Assoc       Date:  1992-07       Impact factor: 1.798

2.  The importance of screening African Americans for prostate cancer.

Authors:  A Farkas
Journal:  J Natl Med Assoc       Date:  1997-12       Impact factor: 1.798

3.  An international comparison of cancer survival: Toronto, Ontario, and Detroit, Michigan, metropolitan areas.

Authors:  K M Gorey; E J Holowaty; G Fehringer; E Laukkanen; A Moskowitz; D J Webster; N L Richter
Journal:  Am J Public Health       Date:  1997-07       Impact factor: 9.308

4.  Completion of therapy by Medicare patients with stage III colon cancer.

Authors:  Sharon A Dobie; Laura-Mae Baldwin; Jason A Dominitz; Barbara Matthews; Kevin Billingsley; William Barlow
Journal:  J Natl Cancer Inst       Date:  2006-05-03       Impact factor: 13.506

5.  Survival of breast cancer patients in Connecticut in relation to socioeconomic and health care access indicators.

Authors:  Anthony P Polednak
Journal:  J Urban Health       Date:  2002-06       Impact factor: 3.671

6.  The contribution of cancer incidence, stage at diagnosis and survival to racial differences in years of life expectancy.

Authors:  Mitchell D Wong; Susan L Ettner; W John Boscardin; Martin F Shapiro
Journal:  J Gen Intern Med       Date:  2009-02-03       Impact factor: 5.128

7.  Racial segregation and disparities in cancer stage for seniors.

Authors:  Jennifer S Haas; Craig C Earle; John E Orav; Phyllis Brawarsky; Bridget A Neville; David R Williams
Journal:  J Gen Intern Med       Date:  2008-03-13       Impact factor: 5.128

8.  The accuracy of prostate cancer staging in a population-based tumor registry and its impact on the black-white stage difference (Connecticut, United States).

Authors:  W L Liu; S Kasl; J T Flannery; A Lindo; R Dubrow
Journal:  Cancer Causes Control       Date:  1995-09       Impact factor: 2.506

9.  Use of androgen deprivation therapy for metastatic prostate cancer in older men.

Authors:  Nancy L Keating; A James O'Malley; Mary McNaughton-Collins; William K Oh; Matthew R Smith
Journal:  BJU Int       Date:  2008-01-08       Impact factor: 5.588

10.  Comparison of breast cancer survival in two populations: Ardabil, Iran and British Columbia, Canada.

Authors:  Alireza Sadjadi; T Gregory Hislop; Chris Bajdik; Morteza Bashash; Anahita Ghorbani; Mehdi Nouraie; Masoud Babaei; Reza Malekzadeh; Parvin Yavari
Journal:  BMC Cancer       Date:  2009-10-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.